Skin Allergy Therapeutics Market by Indication, Route of Administration, Treatment, Distribution Channel - Global Forecast 2025-2030- Product Image

Sale

Skin Allergy Therapeutics Market by Indication, Route of Administration, Treatment, Distribution Channel - Global Forecast 2025-2030

Report
194 Pages
October 2024
Region: Global
360iResearch™
ID: 6011762

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Skin Allergy Therapeutics Market grew from USD 5.04 billion in 2023 to USD 5.43 billion in 2024. It is expected to continue growing at a CAGR of 8.15%, reaching USD 8.73 billion by 2030.

Skin allergy therapeutics encompass treatments designed to alleviate symptoms associated with hypersensitivity reactions of the skin, such as dermatitis, eczema, and urticaria. These conditions often arise from various triggers, including food, drugs, insect stings, or environmental allergens, necessitating a wide application of topical corticosteroids, antihistamines, and immunotherapies. The necessity for these therapeutics is driven by increasing global occurrences of allergic conditions, intensifying demand for novel and more effective treatments. Healthcare facilities, dermatology clinics, and research institutions represent the primary end-use scope, with a rising emphasis on personalized medicine and patient-centric approaches.

Market growth is fueled by technological advancements in drug delivery systems, heightened awareness regarding skin health, and a burgeoning investment in R&D. The emergence of biologics and small molecule inhibitors, specifically tailored for chronic skin allergies, presents lucrative opportunities. Additionally, the growing trend of integrating digital tools for dermatology diagnostics can further enhance treatment efficacy and patient management. However, market expansion is hindered by stringent regulatory pathways, the high cost of treatment development, and potential adverse effects of prolonged medication use.

To capitalize on emerging trends, businesses should explore innovations in non-invasive treatment options and real-time monitoring systems using wearable technology. This demands continuous research into understanding the complex pathophysiology of skin allergies, which can drive the development of targeted therapies. The skin allergy therapeutics market is characterized by competitive dynamics with numerous small and medium enterprises providing innovative solutions, ensuring robust competition and diverse offerings. Nonetheless, continued collaboration with regulatory bodies, investment in patient education, and enhancement of global access to treatments are crucial for overcoming growth barriers. By focusing on personalized therapeutic interventions and expanding the adoption of digital health technologies, stakeholders can secure a proactive stance in this evolving market landscape.

Understanding Market Dynamics in the Skin Allergy Therapeutics Market

The Skin Allergy Therapeutics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising prevalence of skin allergy conditions among population
- Growing awareness of skincare and detection of skin allergies
Market Restraints
- High costs associated with skincare treatments
Market Opportunities
- Robust research activities to develop novel skin allergy therapeutics
- Improved healthcare infrastructure and medical spendings
Market Challenges
- Stringent regulatory requirements for therapeutics development

Exploring Porter’s Five Forces for the Skin Allergy Therapeutics Market

Porter’s Five Forces framework further strengthens the insights of the Skin Allergy Therapeutics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Skin Allergy Therapeutics Market

External macro-environmental factors deeply influence the performance of the Skin Allergy Therapeutics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Skin Allergy Therapeutics Market

The Skin Allergy Therapeutics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Skin Allergy Therapeutics Market

The Skin Allergy Therapeutics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Skin Allergy Therapeutics Market

The Skin Allergy Therapeutics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Skin Allergy Therapeutics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló A/S, Astellas Pharma International B.V., AstraZeneca PLC, Bausch Health Companies Inc, Bayer AG, DBV Technologies Inc., Dr.Reddy's Laboratories Limited, Eisai Co., Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., HYCOR Biomedical, LLC, Johnson & Johnson Consumer Inc., LEO Pharma A/S, Ligand Pharmaceuticals Incorporated, Lincoln Diagnostics, Inc., Merck KGaA, Omega Diagnostics Group PLC, Pfizer Inc., Piramal Enterprises Limited, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Synnat Pharma Private Limited, Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Skin Allergy Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication
- Angioedema
- Contact Dermatitis
- Eczema
- Urticaria
Route of Administration
- Oral
- Parenteral
Treatment
- Immunotherapy
- Oral Medications
- Phototherapy
- Topical Treatments
Distribution Channel
- Offline
  - Drug Stores
  - Retail Pharmacies
- Online

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of skin allergy conditions among population
5.1.1.2. Growing awareness of skincare and detection of skin allergies
5.1.2. Restraints
5.1.2.1. High costs associated with skincare treatments
5.1.3. Opportunities
5.1.3.1. Robust research activities to develop novel skin allergy therapeutics
5.1.3.2. Improved healthcare infrastructure and medical spendings
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for therapeutics development
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Skin Allergy Therapeutics Market, by Indication

6.1. Introduction
6.2. Angioedema
6.3. Contact Dermatitis
6.4. Eczema
6.5. Urticaria

7. Skin Allergy Therapeutics Market, by Route of Administration

7.1. Introduction
7.2. Oral
7.3. Parenteral

8. Skin Allergy Therapeutics Market, by Treatment

8.1. Introduction
8.2. Immunotherapy
8.3. Oral Medications
8.4. Phototherapy
8.5. Topical Treatments

9. Skin Allergy Therapeutics Market, by Distribution Channel

9.1. Introduction
9.2. Offline
9.2.1. Drug Stores
9.2.2. Retail Pharmacies
9.3. Online

10. Americas Skin Allergy Therapeutics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Skin Allergy Therapeutics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Skin Allergy Therapeutics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. SKIN ALLERGY THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. SKIN ALLERGY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. SKIN ALLERGY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. SKIN ALLERGY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SKIN ALLERGY THERAPEUTICS MARKET DYNAMICS
TABLE 7. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANGIOEDEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CONTACT DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ECZEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY URTICARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PHOTOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 42. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 69. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 74. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 160. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 163. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 180. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 185. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 188. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 235. SKIN ALLERGY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 236. SKIN ALLERGY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Skin Allergy Therapeutics market, which are profiled in this report, include:

ALK-Abelló A/S
Astellas Pharma International B.V.
AstraZeneca PLC
Bausch Health Companies Inc
Bayer AG
DBV Technologies Inc.
Dr.Reddy's Laboratories Limited
Eisai Co., Ltd.
Eli Lilly and Company
GlaxoSmithKline PLC
Glenmark Pharmaceuticals Ltd.
Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
HYCOR Biomedical, LLC
Johnson & Johnson Consumer Inc.
LEO Pharma A/S
Ligand Pharmaceuticals Incorporated
Lincoln Diagnostics, Inc.
Merck KGaA
Omega Diagnostics Group PLC
Pfizer Inc.
Piramal Enterprises Limited
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Synnat Pharma Private Limited
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	194
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.43 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.73 Billion
Compound Annual Growth Rate	8.1%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Skin Allergy Therapeutics Market

Exploring Porter’s Five Forces for the Skin Allergy Therapeutics Market

Applying PESTLE Analysis to the Skin Allergy Therapeutics Market

Analyzing Market Share in the Skin Allergy Therapeutics Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Skin Allergy Therapeutics Market

Strategic Recommendations for Success in the Skin Allergy Therapeutics Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Food Allergy Diagnostics & Therapeutics Market by Product Type, Technology, Source, Component, End-User - Global Forecast 2025-2030

Allergy Treatment Market by Type, Treatment Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030

Skin Allergy Therapeutics - Global Strategic Business Report

Peanut Allergy - Pipeline Insight, 2024

Food Allergy - Pipeline Insight, 2024